| 000 | 00904 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517072353.0 | ||
| 264 | 0 | _c20160617 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1558-8238 | ||
| 024 | 7 |
_a10.1172/JCI84088 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAllison, James | |
| 245 | 0 | 0 |
_aA conversation with James Allison. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cJan 2016 |
||
| 300 |
_a3-4 p. _bdigital |
||
| 500 | _aPublication Type: Interview | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aCD28 Antigens _xgenetics |
| 650 | 0 | 4 |
_aCTLA-4 Antigen _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aNeill, Ushma S | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 126 _gno. 1 _gp. 3-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI84088 _zAvailable from publisher's website |
| 999 |
_c25596200 _d25596200 |
||